Superluminal Medicines Forms Scientific Advisory Board
30 Sep 2024 //
GLOBENEWSWIRE
Superluminal Medicines Closes $120 Million Series A Round
09 Sep 2024 //
GLOBENEWSWIRE
Superluminal Launches with $33 Million Seed Round to Fuel its Drug Discovery
28 Aug 2023 //
GLOBENEWSWIRE